. ATF4 is lowly expressed in multiple cancers and represents a prognostic marker.
Figure S2. RET expression promotes osteosarcoma tumorigenesis and BTZ resistance. A,
Venn diagram indicating duplication among the three gene sets regarding cancer (hsa05200), protein processing in endoplasmic reticulum (hsa04141) and ubiquitin mediated proteolysis (hsa04120) in KEGG PATHWAY database. 782 nonredundant genes were obtained. A set of 19 genes were enriched for the three KEGG pathways mentioned above (Combination) and 92 genes (Reference) which were studied or interested by us and were confirmed the interaction in STRING database. B, Relative expression of the 19 genes were determined for all bone-related sarcoma samples (n = 311) in TCGA. C, The interactions of HSPA5, ATF4, CBLC and RET in STRING database. D, The BTZ-resistant subline U-2 OS/BTZ and HOS/BTZ was established. Cells were seeded into 96-well culture plates and incubated for 1-7 days, respectively. MTT assay was performed to measure the cell growth curve. E, Colony formation efficiencies were determined in BTZ-resistant models of U-2 OS and HOS cells treated with BTZ (100 nM). F, Immunofluorescence analysis of GRP78 protein (green) in OS/BTZ cells, in comparison to the parental cells. Nuclei were stained with Hoechst 33342 (blue). Images were taken using the highcontent imaging system. Scale bars, 10 μm. G, Synthetic RET-siRNAs effectively suppressed endogenous RET mRNA in U-2 OS cells. Cells were transfected with 100 nM siRNA targeting RET (#1, 2, 3) or control siRNA (siCon), or cotransfected with ATF4 expression plasmid for 24 h. qRT-PCR quantitative analyses were performed to evaluate the efficiency of RET knockdown.
H, RET colony formation-promoting activity. Control and RET knockdown (siRET#2 and #3) OS or OS/BTZ cells were cultured for 2 weeks with two-day BTZ (100 nM) treatment at the beginning.
Then cells were fixed and stained. I, MTT assay of U-2 OS cells transfected with siRET (#1, 2, 3) or control siRNA in the presence of RTK inhibitor Cabozantinib (CBZ, 5 μM). J, Colony formation efficiencies were determined in RET-overexpressing OS or OS/BTZ cells with BTZ (100 nM) treatment. Error bars represent mean ± SD from three independent experiments (*P < 0.05, **P < 0.01; n.s., non-significant). vectors, cultured in 100 nM for the first two days of the experiment. The cells were fixed, stained, and photographed after two weeks. Error bars represent mean ± SD from three independent experiments (*P < 0.05, **P < 0.01, ***P < 0.001; n.s., non-significant). Data are shown as the mean ± SEM. Statistical significance was determined by Student's t-test. *P < 0.05, **P < 0.01; n.s., non-significant. F, Indirect immunofluorescence detecting the expression of ATF4 in U-2 OS/BTZ cells before subjected to Piperine or Ribociclib for 24 h.
Images were taken using the high-content imaging system. Scale bars, 10 μm. G, OS/BTZ cells transiently transfected with siCon or siATF4 were challenged with piperine or ribociclib for 24 h.
Cell lysates were collected, and the indicated proteins were analysed. Data from representative immunoblots of three independent assays are shown. 
